[go: up one dir, main page]

HU0000283D0 - New process for the production of medicine industrial product - Google Patents

New process for the production of medicine industrial product

Info

Publication number
HU0000283D0
HU0000283D0 HU0000283A HUP0000283A HU0000283D0 HU 0000283 D0 HU0000283 D0 HU 0000283D0 HU 0000283 A HU0000283 A HU 0000283A HU P0000283 A HUP0000283 A HU P0000283A HU 0000283 D0 HU0000283 D0 HU 0000283D0
Authority
HU
Hungary
Prior art keywords
production
new process
industrial product
medicine industrial
formula
Prior art date
Application number
HU0000283A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to HU0000283A priority Critical patent/HU227039B1/hu
Publication of HU0000283D0 publication Critical patent/HU0000283D0/hu
Priority to ES01904235T priority patent/ES2217115T3/es
Priority to PL355726A priority patent/PL211338B1/pl
Priority to HR20020579A priority patent/HRP20020579B1/xx
Priority to AT01904235T priority patent/ATE261949T1/de
Priority to AU32146/01A priority patent/AU3214601A/en
Priority to SK1060-2002A priority patent/SK287171B6/sk
Priority to EP01904235A priority patent/EP1252151B1/en
Priority to DK01904235T priority patent/DK1252151T3/da
Priority to PCT/HU2001/000010 priority patent/WO2001055125A1/en
Priority to DE2001602357 priority patent/DE60102357T2/de
Priority to RU2002122723/04A priority patent/RU2258067C2/ru
Priority to UA2002086977A priority patent/UA73547C2/uk
Priority to SI200130107T priority patent/SI1252151T1/xx
Priority to CNB2004100027829A priority patent/CN1239487C/zh
Priority to CNB018040993A priority patent/CN1177839C/zh
Priority to CZ20022463A priority patent/CZ301236B6/cs
Publication of HUP0000283A2 publication Critical patent/HUP0000283A2/hu
Publication of HUP0000283A3 publication Critical patent/HUP0000283A3/hu
Publication of HU227039B1 publication Critical patent/HU227039B1/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/215—Radicals derived from nitrogen analogues of carbonic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D281/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D281/02—Seven-membered rings
    • C07D281/04—Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D281/08—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D281/12—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with two six-membered rings
    • C07D281/16—[b, f]-condensed

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Steroid Compounds (AREA)
HU0000283A 2000-01-25 2000-01-25 New process for the production of quetiapine and intermediates therefor HU227039B1 (en)

Priority Applications (17)

Application Number Priority Date Filing Date Title
HU0000283A HU227039B1 (en) 2000-01-25 2000-01-25 New process for the production of quetiapine and intermediates therefor
CZ20022463A CZ301236B6 (cs) 2000-01-25 2001-01-24 Zpusob prípravy chetiapinu a jeho meziproduktu
DK01904235T DK1252151T3 (da) 2000-01-25 2001-01-24 Fremgangsmåde til fremstilling af quetiapin og mellemprodukter dertil
DE2001602357 DE60102357T2 (de) 2000-01-25 2001-01-24 Verfahren zur herstellung von quetiapin und intermediate dafür
HR20020579A HRP20020579B1 (en) 2000-01-25 2001-01-24 A process for the preparation of quetiapine and intermediates thereof
AT01904235T ATE261949T1 (de) 2000-01-25 2001-01-24 Verfahren zur herstellung von quetiapin und intermediate dafür
AU32146/01A AU3214601A (en) 2000-01-25 2001-01-24 A process for the preparation of quetiapine and intermediates therefor
SK1060-2002A SK287171B6 (sk) 2000-01-25 2001-01-24 Spôsob prípravy chetiapínu a jeho medziproduktov
EP01904235A EP1252151B1 (en) 2000-01-25 2001-01-24 A process for the preparation of quetiapine and intermediates therefor
ES01904235T ES2217115T3 (es) 2000-01-25 2001-01-24 Procedimiento para la preparacion de quetiapina y de sus productos intermedios.
PCT/HU2001/000010 WO2001055125A1 (en) 2000-01-25 2001-01-24 A process for the preparation of quetiapine and intermediates therefor
PL355726A PL211338B1 (pl) 2000-01-25 2001-01-24 Sposób otrzymywania quetiapiny i związki przejściowe do tego procesu
RU2002122723/04A RU2258067C2 (ru) 2000-01-25 2001-01-24 Способ получения кветиапина и промежуточные соединения
UA2002086977A UA73547C2 (uk) 2000-01-25 2001-01-24 Спосіб одержання кветіапіну (варіанти) і проміжні сполуки
SI200130107T SI1252151T1 (en) 2000-01-25 2001-01-24 A process for the preparation of quetiapine and intermediates therefor
CNB2004100027829A CN1239487C (zh) 2000-01-25 2001-01-24 制备奎替阿平的中间体及所述中间体的制备方法
CNB018040993A CN1177839C (zh) 2000-01-25 2001-01-24 奎替阿平及其中间体的制备方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU0000283A HU227039B1 (en) 2000-01-25 2000-01-25 New process for the production of quetiapine and intermediates therefor

Publications (4)

Publication Number Publication Date
HU0000283D0 true HU0000283D0 (en) 2000-03-28
HUP0000283A2 HUP0000283A2 (hu) 2002-04-29
HUP0000283A3 HUP0000283A3 (en) 2002-11-28
HU227039B1 HU227039B1 (en) 2010-05-28

Family

ID=89978038

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0000283A HU227039B1 (en) 2000-01-25 2000-01-25 New process for the production of quetiapine and intermediates therefor

Country Status (16)

Country Link
EP (1) EP1252151B1 (hu)
CN (2) CN1239487C (hu)
AT (1) ATE261949T1 (hu)
AU (1) AU3214601A (hu)
CZ (1) CZ301236B6 (hu)
DE (1) DE60102357T2 (hu)
DK (1) DK1252151T3 (hu)
ES (1) ES2217115T3 (hu)
HR (1) HRP20020579B1 (hu)
HU (1) HU227039B1 (hu)
PL (1) PL211338B1 (hu)
RU (1) RU2258067C2 (hu)
SI (1) SI1252151T1 (hu)
SK (1) SK287171B6 (hu)
UA (1) UA73547C2 (hu)
WO (1) WO2001055125A1 (hu)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA76088C2 (en) 1999-03-15 2006-07-17 Axys Pharm Inc N-cyanomethyl amides as cysteine protease inhibitors
IL156577A0 (en) 2000-12-22 2004-01-04 Axys Pharm Inc Selective cathepsin s inhibitors and pharmaceutical compositions containing the same
US7030116B2 (en) 2000-12-22 2006-04-18 Aventis Pharmaceuticals Inc. Compounds and compositions as cathepsin inhibitors
BR0212535A (pt) 2001-09-14 2004-10-19 Aventis Pharma Inc Compostos e composições como inibidores de catepsina
US6977256B2 (en) 2001-11-14 2005-12-20 Aventis Pharmaceuticals Inc. Compounds and compositions as cathepsin S inhibitors
EP1495008A1 (en) * 2003-02-22 2005-01-12 Teva Pharmaceutical Industries Limited Synthesis of quetiapine and pharmaceutically acceptable salts thereof
EP2404615A1 (en) 2003-04-23 2012-01-11 Medarex, Inc. Humanized antibodies to interferon alpha receptor-1 (IFNAR-1)
PL195728B1 (pl) * 2003-07-18 2007-10-31 Helm Ag Sposób wytwarzania 11-(1-piperazynylo)dibenzo[b,f][1,4]tiazepiny
ES2223294B2 (es) * 2003-08-08 2005-10-01 Vita Cientifica, S.L. Procedimiento de preparacion de un compuesto farmaceuticamente activo.
CA2538745A1 (en) 2003-09-23 2005-03-31 Fermion Oy Preparation of quetiapine
ATE496038T1 (de) 2003-09-23 2011-02-15 Fermion Oy Verfahren zur herstellung von quetiapin
KR101038389B1 (ko) * 2004-06-23 2011-06-01 에스케이바이오팜 주식회사 11-(4-[2-(2-히드록시에톡시)에틸]-1-피페라지닐)-디벤조[ｂ,ｆ][1,4]티아제핀의 제조방법
WO2006035293A1 (en) * 2004-09-27 2006-04-06 Ranbaxy Laboratories Limited Polymorphic forms of quetiapine hemifumarate
WO2006056772A2 (en) * 2004-11-23 2006-06-01 Pliva Hrvatska D.O.O. Salts of quetiapine
GB0425729D0 (en) * 2004-11-23 2004-12-22 Pliva Res & Dev Ltd Heterocyclic compounds
ES2234447B1 (es) * 2005-03-07 2006-03-01 Union Quimico-Farmaceutica S.A. Procedimiento para la obtencion de un derivado de 11-(4-sustituido-1-piperazinil)dibenzo(b,f)(1,4)tiazepina.
JP2008502707A (ja) 2005-04-14 2008-01-31 テバ ファーマシューティカル インダストリーズ リミティド クエチアピンフマレートの調製方法
US8044038B2 (en) 2005-09-30 2011-10-25 Fermion Oy Crystallization process of quetiapine hemifumarate
SI2262486T1 (sl) 2008-08-01 2013-04-30 Krka, Tovarna Zdravil, D.D., Novo Mesto Sestavek kvetiapina
CN101676275B (zh) * 2008-09-17 2014-05-07 北京德众万全药物技术开发有限公司 一种富马酸喹硫平的制备方法
US20120071649A1 (en) 2009-03-04 2012-03-22 Ranbaxy Laboratories Limited Process for the preparation of quetiapine fumarate

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2683147A (en) * 1949-12-07 1954-07-06 Geigy Ag J R Quaternary ammonium compounds of bis-tertiary aminoalkoxy alkanes
CH422793A (de) * 1961-07-20 1966-10-31 Wander Ag Dr A Verfahren zur Herstellung 11-basisch substituierter Dibenzo(b,f) (1,4)thiazepine
CH476753A (de) * 1962-06-08 1969-08-15 Wander Ag Dr A Verfahren zur Herstellung von 11-basisch substituierter Dibenzo(b,f)(1,4)thiazepine
US3539573A (en) * 1967-03-22 1970-11-10 Jean Schmutz 11-basic substituted dibenzodiazepines and dibenzothiazepines
US3560622A (en) * 1967-10-13 1971-02-02 American Cyanamid Co Trifluoromethyl oxazepines,thiazepines and diazepines as anti-inflammatory agents

Also Published As

Publication number Publication date
CN1239487C (zh) 2006-02-01
PL355726A1 (en) 2004-05-17
HU227039B1 (en) 2010-05-28
HUP0000283A3 (en) 2002-11-28
EP1252151B1 (en) 2004-03-17
HUP0000283A2 (hu) 2002-04-29
DK1252151T3 (da) 2004-07-12
WO2001055125A1 (en) 2001-08-02
ATE261949T1 (de) 2004-04-15
CZ20022463A3 (cs) 2002-10-16
AU3214601A (en) 2001-08-07
CZ301236B6 (cs) 2009-12-16
CN1396916A (zh) 2003-02-12
DE60102357T2 (de) 2005-01-13
HRP20020579B1 (en) 2005-08-31
UA73547C2 (uk) 2005-08-15
SI1252151T1 (en) 2004-08-31
EP1252151A1 (en) 2002-10-30
RU2258067C2 (ru) 2005-08-10
SK10602002A3 (sk) 2002-11-06
RU2002122723A (ru) 2004-01-10
SK287171B6 (sk) 2010-02-08
ES2217115T3 (es) 2004-11-01
HRP20020579A2 (en) 2004-08-31
CN1537847A (zh) 2004-10-20
DE60102357D1 (de) 2004-04-22
PL211338B1 (pl) 2012-05-31
CN1177839C (zh) 2004-12-01

Similar Documents

Publication Publication Date Title
HU0000283D0 (en) New process for the production of medicine industrial product
MY121760A (en) Benzothiazin and benzoxazin derivatives;their preparation and uses
NZ504106A (en) Fused Oxazine, Thiazine and pipyridine compounds, process for their preparation and pharmaceutical compositions containing them
EP0872481A4 (en) DEPSIPEPTIDE DERIVATIVE, METHOD FOR THE PRODUCTION THEREOF AND INTERMEDIATE PRODUCT THEREFOR
IL151327A0 (en) 8,8a-dihydro-indeno [1,2-d] thiazole derivatives, substituted in position 8a, a method for their production and their use as medicaments, e.g. anorectic agents
NO20075071L (no) Fremgangsmate for fremstilling av et 11-(4-substituert-1-piperazinyl) dibenzo [b,f] [1,4]thiazepin dericvat2005
IL150982A0 (en) Process for the preparation of donepezil
TW368497B (en) Process for preparing benzoic acid derivative intermediates and benzothiophene pharmaceutical agents
YU76500A (sh) Hemijska sinzeza morfolinskih derivata
AU2001212914A1 (en) Friedel-craft process for the preparation of thioxanthones
FR2796641B1 (fr) Nouveau procede de preparation de composes benzoperhydroisoindole
IL141394A0 (en) Process for the preparation of imidazodiazepine intermediates
AU3590801A (en) One-pot synthesis of alkyl 3-cyclopropylamino-2-(2,4-dibromo-3-(difluoromethoxy)benzoyl -2-propenoate as a useful intermediate for antibacterial quinolone medicaments
EP1781646A4 (en) PROCESS FOR PREPARING 11- (4- [2- (2-HYDROXYETHOXY) ETHYL] -1-PIPERAZINYL) DIBENZO [B, F] [1,4] THIAZEPINE
PL1660468T3 (pl) Sposób wytwarzania 11-(4-[2-(2-hydroksyetoksy)etylo]-1-piperazynylo-dibenzo[b,f][1,4]tiazepiny
MY120806A (en) Improved process for preparing pharmaceutically valuable norbenzomorphane derivatives.
AU2639999A (en) Intermediate compounds in the synthesis of the a ring moiety of 2-substituted vitamin d derivatives
HUP0203214A3 (en) Process for preparing intermediates applicable for synthesis of hiv protease inhibitor
FR2854403A1 (fr) Nouveau procede et intermediaires de preparation de composes 19-nor-steroides 17-halogenes
MXPA04003628A (es) Derivados de benzoxanina y benzotiazina y composiciones farmaceuticas que los contienen.
ZA200200158B (en) Process for producing dibenzothiazepine derivatives.
EP1319646A4 (en) PROCESS FOR THE PREPARATION OF 3,5-BISALKYLPHENOLENE
IL151326A0 (en) Substituted 8, 8a-dihydro-3ah-indeno[1,2-d] thiazoles, a method for their production and their use as medicaments
ES2190305A1 (es) Compuestos intermedios para la preparacion de mirtazapina y sus procedimientos de obtencion.

Legal Events

Date Code Title Description
HC9A Change of name, address

Owner name: EGIS GYOGYSZERGYAR NYILVANOSAN MUEKOEDOE RESZV, HU

Free format text: FORMER OWNER(S): EGIS GYOGYSZERGYAR RT., HU

MM4A Lapse of definitive patent protection due to non-payment of fees